NCT06966986View on ClinicalTrials.gov

Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma

Active, not recruitingOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

September 11, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

October 1, 2026

Conditions
Liver Carcinoma
Trial Locations (1)

322000

The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu

All Listed Sponsors
lead

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

OTHER

NCT06966986 - Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter